Structural HYFT Technology is used as a navigational layer to parse over the protein predictive platforms AlphaFold-2 and Evolutionary Scale Modeling (ESM)-2 Fold HYFT Technology explores formal and explicit biologically relevant knowledge and connects
OTTAWA, Ontario & CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Health Canada has approved P
Renewable natural gas (biomethane) is now being injected at three of its seven facilities being developed in Europe – Tønder (Denmark), Easy Energia and Calimera (Italy) BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (TSX: ANRG, “the Company”
IMV’s common shares expected to begin trading on a split-adjusted basis on December 13, 2022 DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$IMV #DeliveryPlatform--IMV Inc. (the “Corporation”) (NASDAQ: IMV; TSX: IMV), a clinical-stage
DUBLIN--(BUSINESS WIRE)--The "Healthcare BPO Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global healthcare BPO market is anticipated to grow at a substantial CAGR of 9.3% during the forecast period. Increasing pressu
DUBLIN--(BUSINESS WIRE)--The "Synthetic Small Molecule API Market Share, Size, Trends, Industry Analysis Report, By Application; By Manufacturer; By Region; Segment Forecast, 2022-2030" report has been added to ResearchAndMarkets.com's offering. The glob
Deep Expertise in Intellectual Property to Support Company’s Innovations SEATTLE, BOSTON & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation CAMBRIDGE, England & TORONTO, Canada--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company,
- New findings underscore potential of CYB003 as a novel psychedelic-based therapeutic for the treatment of depression - TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (Cybin or the Company), a biopharmaceutical company focused on
CEPI and VBI expand scope of partnership to target multiple coronavirus threats Vaccine platform presents multiple antigens, mimicking natural form of the virus OSLO, Norway & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Coalition for Epidemic Preparedness
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.